| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/14/2000 | WO2000033789A3 Inhalation powders |
| 09/14/2000 | WO2000027365A8 Functionalized nanocrystals and their use in detection systems |
| 09/14/2000 | WO2000027358A3 Aqueous composition containing two acid-functional vinyl polymers |
| 09/14/2000 | WO2000024382B1 Method for producing solid spherical materials containing a biologically active substance |
| 09/14/2000 | DE19911097A1 Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen A process for the preparation of solid dosage forms cyclodextrin |
| 09/14/2000 | DE19911064A1 Dosieraerosole mit Isobutan als Treibmittel MDIs containing isobutane as a propellant |
| 09/14/2000 | DE19908787A1 Transdermal therapeutic system for administration of fenoterol and formoterol, useful for treating obstructive respiratory disorders |
| 09/14/2000 | DE19907257A1 Mittel zur Steuerung der Diffusion von Injektionslösungen Means for controlling the diffusion of solutions for injection |
| 09/14/2000 | CA2366719A1 Solubilization of polyunsaturated fatty acids and their derivatives by formation of inclusion complexes with y-cyclodextrin and their use in pharmaceutical, cosmetic or food compositions |
| 09/14/2000 | CA2365869A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | CA2364455A1 Radioactive microsphere and method for preparation thereof |
| 09/14/2000 | CA2364257A1 Liposome preparations |
| 09/14/2000 | CA2364253A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | CA2364226A1 Controlled-release compositions of betahistine |
| 09/14/2000 | CA2364198A1 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds |
| 09/14/2000 | CA2363134A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
| 09/13/2000 | EP1035196A1 Improved pellet formulations |
| 09/13/2000 | EP1034839A1 Nanocapsules based on dendritic polymers |
| 09/13/2000 | EP1034794A1 A formulation of dihydroartemisinin for the control of wide spectrum of malaria |
| 09/13/2000 | EP1034793A1 Preventives/remedies for glaucoma |
| 09/13/2000 | EP1034781A2 Oral adhesive sheet and oral adhesive preparation |
| 09/13/2000 | EP1034780A2 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 09/13/2000 | EP1034326A1 Process for the production of protein fibres and products thereof |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034207A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 09/13/2000 | EP1034007A1 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml |
| 09/13/2000 | EP1033999A1 Compositions of leukaemia inhibitory factor |
| 09/13/2000 | EP1033998A1 Method of suppressing beta-amyloid-related changes in alzheimer's disease |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033992A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 09/13/2000 | EP1033991A1 Mometasone furoate suspensions for nebulization |
| 09/13/2000 | EP1033988A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 09/13/2000 | EP1033987A2 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 09/13/2000 | EP1033986A1 Formulations comprising dissolved paroxetine |
| 09/13/2000 | EP1033984A1 Concentrate for medical solution and use thereof |
| 09/13/2000 | EP1033978A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 09/13/2000 | EP1033977A2 Pharmaceutical compositions having the shape of powders of cross-linked polymers loaded with drugs and related preparation process by supercritical fluids |
| 09/13/2000 | EP1033976A1 Microsphere reservoirs for controlled release application |
| 09/13/2000 | EP1033974A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 09/13/2000 | EP1033973A1 Encapsulation method |
| 09/13/2000 | EP1033972A1 Drug delivery system with two-step targeting |
| 09/13/2000 | EP1033971A1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/13/2000 | EP1033970A1 Novel formulation for use in pain management |
| 09/13/2000 | EP1033969A1 Compositions adapted for prolonged residence in the nasal pharynx |
| 09/13/2000 | EP1033953A1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 09/13/2000 | EP1033947A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 09/13/2000 | EP0877606B1 Effervescent ibuprofen preparation and process for the production thereof |
| 09/13/2000 | EP0851761A4 Anti-intoxication composition |
| 09/13/2000 | EP0850050B1 Oral fast-dissolving compositions for dopamine agonists |
| 09/13/2000 | EP0806948B1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 09/13/2000 | EP0760655B1 Multilayered controlled release pharmaceutical dosage form |
| 09/13/2000 | EP0746331B1 Convertible microemulsion formulations |
| 09/13/2000 | EP0729351B1 Vesicles with controlled release of actives |
| 09/13/2000 | EP0683664B1 Taxol formulation |
| 09/13/2000 | CN2395723Y Vernier supporting structure for capsule filling machine |
| 09/13/2000 | CN1266371A Stable insulin formulations |
| 09/13/2000 | CN1266370A Activated vitamin D3 emulsion-type lotions |
| 09/13/2000 | CN1266369A Dexamethasone gel |
| 09/13/2000 | CN1266081A Improved granular material formula |
| 09/13/2000 | CN1265923A Nano-emulsion based on fatty glyceride and application thereof |
| 09/13/2000 | CN1265921A Erythropoiesis for treating anemia of family and raised animals |
| 09/13/2000 | CN1265913A Choulingdan extract and process for preparing same |
| 09/13/2000 | CN1265909A Capsule for treating rhinitis |
| 09/13/2000 | CN1265908A Cough-relieving medicine |
| 09/13/2000 | CN1265907A Lozenge for curing chronic bronchitis and preparation process thereof |
| 09/13/2000 | CN1265906A Rhododendron mariesii injection and preparation process thereof |
| 09/13/2000 | CN1265904A Traditional Chinese medicinal pill with function of prolonging life |
| 09/13/2000 | CN1265903A Traditional Chinese powder medicine for treating cough and preparation process thereof |
| 09/13/2000 | CN1265900A Bear gallbladder lozenge and preparation process thereof |
| 09/13/2000 | CN1265888A Medicinal preparations of anti-allergic reaction compound chromonatohydroxypropyl sodium |
| 09/13/2000 | CN1265886A Quick-acting powder for giving up smoking |
| 09/13/2000 | CN1265885A Oil-soluble vitamin powder and making process thereof |
| 09/13/2000 | CN1265884A Oral nifedipine pill and preparation process |
| 09/13/2000 | CN1265883A Base material of suppository |
| 09/13/2000 | CN1265882A Process for preparing medicinal granule |
| 09/13/2000 | CN1265879A Nano-emulsion based on dehydrated sorbitol fatty acid ester and application thereof |
| 09/13/2000 | CN1056413C New process for making crystalline sugar and products resulting therefrom |
| 09/13/2000 | CN1056407C Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns |
| 09/13/2000 | CN1056310C Granule medicine for treating gallbladder, pancreas and stomach diseases |
| 09/13/2000 | CN1056306C Plaster for treating traumatic injury and preparation process thereof |
| 09/13/2000 | CN1056294C Refreshing tea |
| 09/13/2000 | CN1056292C Eyesight improving granule and its preparation process |
| 09/13/2000 | CN1056289C Antiphthitic medicine |
| 09/13/2000 | CN1056288C Fuxin powder medicine and preparation process thereof |
| 09/13/2000 | CN1056287C Traditional Chinese medicine for reducing blood-lipid and its preparation process |
| 09/13/2000 | CN1056281C Medicine for treating burn and preparation process thereof |
| 09/13/2000 | CN1056278C Slow released capsule |
| 09/13/2000 | CN1056277C Preparation process for tablet containing granule structure |
| 09/12/2000 | US6118011 Mixture of lipid and taxane |
| 09/12/2000 | US6117982 Microbead coupled with binding molecules which lack fc portions and are specific for cd2, cd3 or other t cell receptor-linked components, cd4, cd5 or cd8; anticarcinogenic agents and treatment of infections |
| 09/12/2000 | US6117949 Water solubility at low temperature; drug delivery |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117868 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| 09/12/2000 | US6117864 Methods employing stable preparation containing azelastine hydrochloride |
| 09/12/2000 | US6117859 Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides |
| 09/12/2000 | US6117858 For specific delivery of biologically active substances to achieve lower doses and for improved efficacy with drugs such as oligonucleotides and polynucleotides with problems in achieving therapeutic concentrations at targeted organs |
| 09/12/2000 | US6117857 Pharmaceutical composition |
| 09/12/2000 | US6117479 Electrostatic coating |
| 09/12/2000 | US6117456 Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
| 09/12/2000 | US6117455 A sustained-release microcapsule that has a high entrapment of a water-soluble drug and causes a small initial release, microcapsule comprising an amorphous water-soluble physiologically active substance and a polymer |